VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

TRESTLE BIO

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 79 out of 100

Bioengineered Therapies for Kidney Disease

Also known as Trestle Biotherapeutics

  • Biotech & therapeutics
Status
Operatingas of 2026-09-20Source (opens in a new tab)
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Trestle is developing an implantable therapeutic tissue that will be delivered to patients suffering from end stage renal disease (ESRD).

About the company

Status notes
Trestle Bio is a preclinical stage company developing bioengineered kidney tissues for patients suffering from end stage renal disease (ESRD).
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy